Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity
Open accessThe DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
Abstract
Tumours often engage the lymphatic system in order to invade and metastasize. The tumour-draining lymph node may be an immune-privileged site that protects the tumour from host immunity, and lymph flow that drains tumours is often increased, enhancing communication between the tumour and the sentinel node. In addition to increasing the transport of tumour antigens and regulatory cytokines to the lymph node, increased lymph flow in the tumour margin causes mechanical stress-induced changes in stromal cells that stiffen the matrix and alter the immune microenvironment of the tumour. We propose that synergies between lymphatic drainage and flow-induced mechanotransduction in the stroma promote tumour immune escape by appropriating lymphatic mechanisms of peripheral tolerance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although this shear stress is very small when compared with the intravascular shear stress, it can still stimulate some oncogenic signaling pathways on cancer cells [150] as well as upregulate TGFβ and activate fibroblast contraction to stiffen the ECM [151].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [151]
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 1×
“The hypoxia that is generated by a rapidly growing tumour mass drives aberrant tumour angiogenesis, which is one of the most well-studied hallmarks of cance”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“Myeloid-derived suppressor cells (MDSCs), which are important for immune suppression, as well as for tumour angiogenesis and invasio”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101 · cited 1×
“Additionally, transgenic expression of lysyl oxidase in mice could induce the invasion of otherwise non-invasive cancer cell”
BackgroundTensional homeostasis and the malignant phenotype
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., Reinhart-King, C. A., Margulies, S. S., Dembo, M., Boettiger, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.010 · Cited by 3,941
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Collective cell migration in morphogenesis, regeneration and cancer
Friedl, P., & Gilmour, D. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2720 · Cited by 2,712 · cited 1×
“Fibroblasts and tumour cells can also migrate along bundled collagen fibres that radiate outwards from the tumou”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222 · cited 1×
“, which, together with the leaky vessels, leads to increased interstitial fluid pressure (IFP) within the tumou”
BackgroundCollagen reorganization at the tumor-stromal interface facilitates local invasion
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-38 · Cited by 1,804 · cited 1×
“Fibroblasts and tumour cells can also migrate along bundled collagen fibres that radiate outwards from the tumou”
BackgroundGaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“Migrating CAFs, in turn, use proteases and generate forces to tunnel through the matrix, thereby leading collective tumour cell invasio”
Background
Research works printed but not linked: 1
- Ruddell, A., Harrell, M. I. & Furuya, M. Sentinel lymph node lymphangiogenesis and increased lymph flow in murine tumor metastasis. Clin. Exp. Metast. 26, 883–884 (2009).
Cited by
Items 201–300 of 549
Nucleic acids presenting polymer nanomaterials as vaccine adjuvants
Comberlato, A., Paloja, K., & Bastings, M. M. C. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01222b · Cited by 41
Quantification of the Whole Lymph Node Vasculature Based on Tomography of the Vessel Corrosion Casts
Jafarnejad, M., Ismail, A. Z., Duarte, D., Vyas, C., Ghahramani, A., Zawieja, D. C., Celso, C. L., Poologasundarampillai, G., & Moore, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-49055-7 · Cited by 46
Immune Checkpoint Therapy: Tumor Draining Lymph Nodes in the Spotlights
Fransen, M. F., van Hall, T., & OSSENDORP, F. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179401 · Cited by 45
“Beyond these factors, it was described that a growing tumor physically impacts lymphatics and sentinel lymph nodes such that the architecture and chemokine (receptors) of TDLNs are different from NDLN [19].”
BackgroundSystemic Interleukins’ Profile in Early and Advanced Colorectal Cancer
Czajka‐Francuz, P., Cisoń-Jurek, S., Czajka, A., Kozaczka, M., Wojnar, J., Chudek, J. T., & Francuz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010124 · Cited by 42
“The cytokine profile reflects numerous processes, including angiogenesis, lymphangiogenesis [304], increased systemic inflammatory response, and acquisition of a stem-like phenotype by cancer cells [290,305], factors facilitating metastasis.”
BackgroundTan, K., & Naylor, M. J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.876451 · Cited by 48
“The presence of these antigens stimulates the recruitment of macrophages and DCs to the tumor site (19).”
BackgroundA contact line pinning based microfluidic platform for modelling physiological flows
Tung, C.-K., Krupa, O., Apaydin, E., Liou, J., Diaz-Santana, A., Kim, B. J., & Wu, M. (2013) · Lab on a Chip · doi:10.1039/c3lc50489a · Cited by 43
Balsat, C., Blacher, S., Herfs, M. F., de Velde, M. V., Signolle, N., Sauthier, P. G., Pottier, C., Gofflot, S., Cuypere, M. D., Delvenne, P., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1265718 · Cited by 39
“, growth factors, cytokines, soluble antigens and antigen-presenting cells) to SLN, influencing thereby the immune microenvironment.(26) All together, these experimental data highlight the importance to evaluate both the lymphovascular and the immunoreactive profiles when characterizing the pre-metastatic remodeling o…”
BackgroundMatsuda, T., Miyauchi, E., Hsu, Y.-W., Nagayama, S., Kiyotani, K., Zewde, M. G., Park, J., Kato, T., Harada, M., Matsui, S., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1588085 · Cited by 38
“TDLNs are usually removed at the time of surgical treatment and are considered to be tissues to initiate the antitumor immune responses.(9,10) The tumor cells”
BackgroundMishra, S. B., Bhatt, T., Kumar, H., Jain, R., Shilpi, S., & Jain, V. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1101320 · Cited by 37
Lymphatic system regulation of anti-cancer immunity and metastasis
Lei, P., Fraser, C. S., Jones, D., Ubellacker, J. M., & Padera, T. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1449291 · Cited by 45
“The reduction of tumor-draining lymphatic vessel contraction could lead to the elevation of interstitial fl uid pressure in primary tumor sites (119, 120), which might drive cancer cells to migrate toward functional lymphatic vessels that are mainly positioned in the tumor margin (68).”
BackgroundKang, T., Park, C., & Lee, B.-J. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0847-0 · Cited by 35
“tial flows in the tumor microenvironment (Michor et al. 2011; Swartz and Lund 2012).”
Closset, L., Gultekin, O., Salehi, S., Sarhan, D., Lehti, K., & Gonzalez‐Molina, J. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.07.003 · Cited by 45
Green, V. L., Michno, A., Stafford, N. D., & Greenman, J. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1395-9 · Cited by 36
“Therefore, the presence of intratumoural Tregs and the balance of these with T helper and T cytotoxic cells are more likely to be of relevance to immune evasion [26, 27].”
BackgroundRecent studies on micro-/nano-sized biomaterials for cancer immunotherapy
Park, O., Yu, G., Jung, H., & Mok, H. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0288-2 · Cited by 35
Regulation of CTL Infiltration Within the Tumor Microenvironment
Church, S., & Galon, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_3 · Cited by 37
Jiang, L., Jung, S., Zhao, J., Kasinath, V., Ichimura, T., Joseph, J., Fiorina, P., Liss, A. S., Shah, K., Annabi, N., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101045 · Cited by 38
“Spread of cancer cells from TDLNs is an important mechanism for the formation of distant metastasis and tumor immunity [19,58,59].”
Kalli, M., Mpekris, F., Charalambous, A., Michael, C., Stylianou, C., Voutouri, C., Hadjigeorgiou, A. G., Papoui, A., Martin, J. D., & Stylianopoulos, T. (2024) · Communications Biology · doi:10.1038/s42003-024-07268-1 · Cited by 37
Microfluidic culture models to study the hydrodynamics of tumor progression and therapeutic response
Buchanan, C., & Rylander, M. N. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24944 · Cited by 34
“As a result, non-uniform cytokine gradients and abnormal flow shear stresses are present, which can greatly influence tumor and stromal cell behavior, immune response, as well as delivery and efficacy of therapeutic modalities (Swartz and Lund, 2012).”
BackgroundPolymeric mechanical amplifiers of immune cytokine-mediated apoptosis
Mitchell, M. J., Webster, J., Chung, A., Guimarães, P. P. G., Khan, O. F., & Langer, R. (2017) · Nature Communications · doi:10.1038/ncomms14179 · Cited by 34
Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer
Krantz, D., Hartana, C. A., Winerdal, M. E., Johansson, M., Alamdari, F. I., Jakubczyk, T., Huge, Y., Aljabery, F. A.-S., Palmqvist, K., Zirakzadeh, A. A., et al. (2018) · European Urology · doi:10.1016/j.eururo.2018.06.048 · Cited by 34
Competing Fluid Forces Control Endothelial Sprouting in a 3-D Microfluidic Vessel Bifurcation Model
Akbari, E., Spychalski, G. B., Rangharajan, K. K., Prakash, S., & Song, J. W. (2019) · Micromachines · doi:10.3390/mi10070451 · Cited by 37
Luque‐González, M. A., Reis, R. L., Kundu, S. C., & Caballero, D. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000045 · Cited by 36
Matrix biophysical cues direct mesenchymal stromal cell functions in immunity
Wong, S. W., Lenzini, S. B., Giovanni, R., Clark-Knowles, K. V., & Shin, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.07.075 · Cited by 40
Recent advance in cell patterning techniques: Approaches, applications and future prospects
Yang, W., Qin, Y., Wang, Z., Yu, T., Chen, Y., & Ge, Z. (2021) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2021.113229 · Cited by 36
New tools for immunologists: models of lymph node function from cells to tissues
Ozulumba, T., Montalbine, A. N., Ortiz-Cárdenas, J. E., & Pompano, R. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183286 · Cited by 37
Microengineered tumor models: insights & opportunities from a physical sciences-oncology perspective
DelNero, P., Song, Y. H., & Fischbach, C. (2013) · Biomedical Microdevices · doi:10.1007/s10544-013-9763-y · Cited by 34
A robust in vitro model for trans-lymphatic endothelial migration
Xiong, Y., Brinkman, C. C., Famulski, K. S., Mongodin, E. F., Lord, C. J., Hippen, K. L., Blazar, B. R., & Bromberg, J. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-01575-w · Cited by 36
Extracellular vesicles on the move: Traversing the complex matrix of tissues
Arif, S., & Moulin, V. J. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151372 · Cited by 40
Delivery of Nanoconstructs in Cancer Therapy: Challenges and Therapeutic Opportunities
Saw, W. S., Anasamy, T., Foo, Y. Y., Kwa, Y. C., Kue, C. S., Yeong, C. H., Kiew, L. V., Lee, H. B., & Chung, L. Y. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000206 · Cited by 35
Shaping of Peripheral T Cell Responses by Lymphatic Endothelial Cells
Humbert, M., Hugues, S., & Dubrot, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00684 · Cited by 32
“In the context of solid tumors, lymph flow from tumors is elevated, driving intense interstitial flow in the tumor stroma and increasing lymphatic drainage from the tumor to the draining LN (57).”
BackgroundMierke, C. T. (2024) · Biomolecules · doi:10.3390/biom14020184 · Cited by 34
Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment
Kalli, M., & Stylianopoulos, T. (2024) · APL Bioengineering · doi:10.1063/5.0183302 · Cited by 34
Mani, V., Lyu, Z., Kumar, V., Ercal, B., Chen, H., Malhotra, S. V., & Demirci, U. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800223 · Cited by 34
On-chip modeling of tumor evolution: Advances, challenges and opportunities
Li, C., Holman, J. B., Shi, Z., Qiu, B., & Ding, W. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100724 · Cited by 39
“Blood vessels not only supply oxygen and nutrients for the growth of solid tumors, but they are also an important pathway for tumor metastasis [190,191].”
BackgroundBiomechanical forces in tissue engineered tumor models
Chim, L. K., & Mikos, A. G. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.03.004 · Cited by 36
Hartana, C. A., Bergman, E. A., Zirakzadeh, A. A., Krantz, D., Winerdal, M. E., Winerdal, M., Johansson, M., Alamdari, F. I., Jakubczyk, T., Glise, H., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200079 · Cited by 33
Melanoma-derived mediators can foster the premetastatic niche: crossroad to lymphatic metastasis
Suman, S., & Markovic, S. N. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.07.002 · Cited by 32
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
Magalhaes, I., Carvalho‐Queiroz, C., Hartana, C. A., Kaiser, A. M., Lukic, A., Mints, M., Nilsson, O., Grönlund, H., Mattsson, J., & Berglund, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1608179 · Cited by 32
“leads to recruitment and expansion of immunosuppressive cells [114], and together with the accumulation of interstitial”
BackgroundHot or cold: Bioengineering immune contextures into in vitro patient-derived tumor models
Too, N. S. H., Ho, N. C. W., Adine, C., Iyer, N. G., & Fong, E. L. S. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.001 · Cited by 34
Greenlee, J. D., Liu, K., Lopez‐Cavestany, M., & King, M. R. (2022) · Molecules · doi:10.3390/molecules27175430 · Cited by 36
Emerging roles of podoplanin in vascular development and homeostasis
Pan, Y., & Xia, L. (2015) · Frontiers of Medicine · doi:10.1007/s11684-015-0424-9 · Cited by 36
“Increased expression of PDPN is commonly found in many types of tumors, especially in squamous carcinomas [2,56–58].”
BackgroundKilarski, W. W., Muchowicz, A., Wachowska, M., Mężyk-Kopeć, R., Gołąb, J., Swartz, M. A., & Nowak-Sliwinska, P. M. (2013) · Angiogenesis · doi:10.1007/s10456-013-9365-6 · Cited by 31
“and tumor immune tolerance [10, 40], and thus developing strategies to destroy pathological lymphatic vessels may be”
BackgroundSelf-citationProgress of immune checkpoint therapy in the clinic (Review)
Fan, Y., Zhang, C., Jin, S., Gao, Z., Cao, J., Wang, A., Li, D., Wang, Q., Sun, X., & Bai, D. (2018) · Oncology Reports · doi:10.3892/or.2018.6819 · Cited by 35
“When tumor‑specific T cells encounter tumor antigens in tumor-draining lymph nodes, an effective immune response that attacks tumor cells develops (7).”
Engineered fluidic systems to understand lymphatic cancer metastasis
Greenlee, J. D., & King, M. R. (2020) · Biomicrofluidics · doi:10.1063/1.5133970 · Cited by 31
Multistep, effective drug distribution within solid tumors
Shemi, A., Khvalevsky, E. Z., Gabai, R. M., Domb, A. J., & Barenholz, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5051 · Cited by 32
“An additional aspect to be further studied is the correlation between prolonged intratumoral delivery and lymphatic and interstitial flow in the tumor microenvironment and the effect on tumor immunology [54, 55].”
BackgroundMechanosensing in Developing Lymphatic Vessels
Planas‐Paz, L., & Lammert, E. (2013) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-7091-1646-3_3 · Cited by 34
“This is possible, since the pressure inside lymphatic capillaries is usually lower than the interstitial fluid pressure (Planas-Paz and Lammert 2013; Schmid-Schonbein 1990; Swartz and Lund 2012).”
BackgroundZhang, W., Hu, X., Cheng, W., Zhang, L., Chen, Y., Fu, Q., Liu, L., & Fan, S. (2025) · BMEMat · doi:10.1002/bmm2.70019 · Cited by 39
Lipid-based nanoparticles for cancer immunotherapy
Fan, S., Han, H., Yan, Z., Lu, Y., He, B., & Zhang, Q. (2023) · Medical Review · doi:10.1515/mr-2023-0020 · Cited by 33
“This advance will contribute to our comprehensive understanding of the influence and fate of nanoparticles in the immune microenvironment [273].”
BackgroundHarnessing phytochemicals: Innovative strategies to enhance cancer immunotherapy
Zhu, Q., Zhang, R., Zhao, Z., Xie, T., & Sui, X. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101206 · Cited by 37
Perfused Three-dimensional Organotypic Culture of Human Cancer Cells for Therapeutic Evaluation
Wan, X., Ball, S., Willenbrock, F. W., Yeh, S. A., Vlahov, N., Koennig, D., Green, M., Brown, G., Jeyaretna, D. S., Li, Z., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09686-0 · Cited by 28
Serrano, J. C., Gillrie, M. R., Li, R., Ishamuddin, S. H., Moeendarbary, E., & Kamm, R. D. (2023) · Advanced Science · doi:10.1002/advs.202302903 · Cited by 35
Zhang, Y., O’Mahony, A. P., He, Y., & Barber, T. J. (2024) · Biofabrication · doi:10.1088/1758-5090/ad22ee · Cited by 31
“The cellular microenvironment is another crucial factor that influences cell activity [159, 176–178].”
The Role of Lymphatic Endothelial Cells in Liver Injury and Tumor Development
Kornek, M. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00548 · Cited by 30
A multiphase model for exploring tumor cell migration driven by autologous chemotaxis
Waldeland, J. O., & Evje, S. (2018) · Chemical Engineering Science · doi:10.1016/j.ces.2018.06.076 · Cited by 28
Andreou, T., Neophytou, C., Kalli, M., Mpekris, F., & Stylianopoulos, T. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638186 · Cited by 30
Zhu, L., Fan, X., Wang, B., Liu, L., Yan, X., Zhou, L., Zeng, Y. C., Poznansky, M. C., Wang, L., Chen, H., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.030 · Cited by 27
The Role of Fluid Shear and Metastatic Potential in Breast Cancer Cell Migration
Riehl, B. D., Kim, E., Lee, J. S., Duan, B., Yang, R., Donahue, H. J., & Lim, J. Y. (2020) · Journal of Biomechanical Engineering · doi:10.1115/1.4047076 · Cited by 29
The Hippo pathway drives the cellular response to hydrostatic pressure
Park, J., Jia, S., Salter, D. M., Bagnaninchi, P., & Hansen, C. G. (2022) · The EMBO Journal · doi:10.15252/embj.2021108719 · Cited by 29
“…may contribute to elevated IFP in solid tumours, including blood vessel leakiness, contraction mediated by stromal fibroblasts, overall changes to the interstitial matrix composition, and lymph vessel abnormalities (Heldin et al , 2004; Myers et al , 2007; Swartz & Lund, 2012; Wiig & Swartz, 2012).”
Peritumoral interstitial fluid flow velocity predicts survival in cervical carcinoma
Hompland, T., Lund, K. V., Ellingsen, C., Kristensen, G. B., & Rofstad, E. K. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.09.011 · Cited by 27
“Fifth, increased interstitial and lymphatic fluid flow may decrease the sentinel lymph node immunity to metastatic tumor cells [28,29].”
BackgroundHockemeyer, K., Janetopoulos, C., Terekhov, A., Hofmeister, W., Vilgelm, A., Costa, L., Wikswo, J. P., & Richmond, A. (2014) · Biomicrofluidics · doi:10.1063/1.4890330 · Cited by 26
Early diagnosis of lymph node metastasis: Importance of intranodal pressures
Miura, Y., Mikada, M., Ouchi, T., Horie, S., TAKEDA, K., Yamaki, T., Sakamoto, M., Mori, S., & Kodama, T. (2015) · Cancer Science · doi:10.1111/cas.12873 · Cited by 26
Piersiala, K., da Silva, P. F. N., Lagebro, V., Kolev, A., Starkhammar, M., Elliot, A., Marklund, L., Munck‐Wikland, E., Margolin, G., Georén, S. K., et al. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101469 · Cited by 28
“It is now hypothesized that the ICI efficacy relies predominantly on an influx of newly primed T cells from TDLNs into TME, rather than reinvigorating exhausted and fully differentiated T cells infiltrating tumours [42,43].”
BackgroundHylander, B. L., Sen, A., Beachy, S. H., Pitoniak, R., Ullas, S., Gibbs, J. F., Qiu, J., Prey, J. D., Fetterly, G. J., & Repasky, E. A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.047 · Cited by 26
“Additionally, the elevated IFP results in directional flow of fluid out of the tumor thereby reducing retention of drugs which are delivered [11, 12].”
BackgroundTähtinen, S., Blattner, C., Vähä-Koskela, M. J. V., Saha, D., Siurala, M., Parviainen, S., Utikal, J. S., Kanerva, A., Umansky, V., & Hemminki, A. (2016) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000144 · Cited by 27
Kim, S.-H., Ahn, K., & Park, J. Y. (2017) · Lab on a Chip · doi:10.1039/c7lc00371d · Cited by 28
Kenny, T. C., Schmidt, H., Adelson, K. B., Hoshida, Y., Koh, A. P., Shah, N., Mandeli, J., Ting, J., & Germain, D. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0342 · Cited by 29
“Interstitial fluid (IF) originates from the blood and infiltrates tissues where it occupies all extracellular space to eventually be reabsorbed by the lymph nodes (1, 2).”
BackgroundPhysiological Fluid Flow Moderates Fibroblast Responses to TGF‐β1
Nithiananthan, S., Crawford, A., Cooper‐Knock, J., Lambert, D., & Whawell, S. A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25767 · Cited by 28
Delivery of Biomolecules via Extracellular Vesicles
Stranford, D. M., & Leonard, J. N. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.08.002 · Cited by 26
Assessing multiparametric drug response in tissue engineered tumor microenvironment models
Harris, A. R., Yuan, J. X., & Munson, J. M. (2017) · Methods · doi:10.1016/j.ymeth.2017.12.010 · Cited by 26
“Fluid flow has been shown to have profound effects on tumor cell behavior within the microenvironment [8,19], and drug delivery via fluid flowmore closely recapitulates how drugs are delivered in vivo, draining from leaky vasculature through the tumor bulk and stroma, eventually draining into collecting lymphatics [42…”
BackgroundHydrogels as a New Platform to Recapitulate the Tumor Microenvironment
Ermis, M., Çalamak, S., Calibasi‐Kocal, G., Güven, S., Durmus, N. G., Rizvi, I., Hasan, T. G., Hasırcı, N., Hasırcı, V., & Demirci, U. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813339-2.00015-3 · Cited by 39
Aragon‐Sanabria, V., Kim, G. B., & Dong, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_7 · Cited by 26
Tyrosinase-Loaded Multicompartment Microreactor toward Melanoma Depletion
Godoy‐Gallardo, M., Labay, C., & Hosta‐Rigau, L. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b20275 · Cited by 24
Belotti, Y., McGloin, D., & Weijer, C. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2000686117 · Cited by 24
The emerging promise of tumour mechanobiology in cancer treatment
Papavassiliou, K. A., Basdra, E. K., & Papavassiliou, A. G. (2023) · European Journal of Cancer · doi:10.1016/j.ejca.2023.112938 · Cited by 25
Xu, Y., Miller, C. P., Tykodi, S. S., Akilesh, S., & Warren, E. H. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1387198 · Cited by 31
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
Sun, M., Garnier, L., Chevalier, R., Roumain, M., Wang, C., Angelillo, J., Montorfani, J., Pick, R., Brighouse, D., Fournier, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55969-w · Cited by 30
Immune microenvironment of tumor-draining lymph nodes: insights for immunotherapy
Wei, J., Li, D., Long, H., & Han, M. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1562797 · Cited by 33
“Consequently, the increased fl ow of lymphatic fl uid enhances the accumulation of tumor-derived factors in the TDLNs, further suppressing the local immune environment and accelerating tumor metastasis to these lymph nodes (38).”
Fuh, K. F., Shepherd, R. D., Withell, J. S., Kooistra, B. K., & Rinker, K. D. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01473-0 · Cited by 27
Zhang, L., Li, M., Zhu, J., Zhang, Y., Xiao, Y., Dong, M., Zhang, L., & Wang, J. (2022) · European Radiology · doi:10.1007/s00330-022-09290-5 · Cited by 23
“On the one hand, HCC patients with a higher MVI grade have more aggressive disease, with greater abnormal flow and more leaky tumor blood vessels, which might lead to an increase in tumor interstitial fluid pressure and further result in increased TS values [33, 34].”
BackgroundToluene Diisocyanate (TDI) Disposition and Co-Localization of Immune Cells in Hair Follicles
Nayak, A. P., Hettick, J. M., Siegel, P. D., Anderson, S. E., Long, C. M., Green, B. J., & Beezhold, D. H. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu079 · Cited by 23
“The uptake of these antigens arriving in the DLN in soluble form is reliant on antigen properties such as molecular size (Gretz et al., 2000; Lammermann and Sixt, 2008; Swartz and Lund, 2012).”
BackgroundFujita, S., & Ikeda, T. (2016) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2016.09.052 · Cited by 23
Kang, T., Park, C., Meghani, N. M., Tran, T. T. D., Tran, P. H. L., & Lee, B. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060555 · Cited by 23
“In tumor cells, interstitial shear stress plays a vital role in promoting tumor metastasis, lymphatic drainage, and drug delivery efficiency to cancer cells [9].”
BackgroundInsights Into Unveiling a Potential Role of Tertiary Lymphoid Structures in Metastasis
Mustapha, R., Ng, K., Monypenny, J., & Ng, T. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.661516 · Cited by 24
“Decreased fluid drainage coupled with an increase in tissue fluids leaking from newly formed hyper permeable blood vessels results in increased interstitial fluid pressure (IFP) which creates sheer stress on the tumoral and stromal cells in the microenvironment (Swartz and Lund, 2012; Sefidgar et al., 2015).”
BackgroundStimuli-Responsive Nanomaterials for Tumor Immunotherapy
Li, X., Hou, D., Wu, J.-C., Zhang, P., Wang, Y.-Z., Lv, M.-Y., Yi, Y., & Xu, W. (2024) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c00388 · Cited by 23
Autophagy transduces physical constraints into biological responses
Dupont, N., & Codogno, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.021 · Cited by 24
Leveraging cellular mechano-responsiveness for cancer therapy
Hyun, J., & Kim, H. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.11.006 · Cited by 23
Message in a Bottle: Endothelial Cell Regulation by Extracellular Vesicles
Palazzo, C., D’Alessio, A., & Tamagnone, L. (2022) · Cancers · doi:10.3390/cancers14081969 · Cited by 23
Modulating tumor mechanics with nanomedicine for cancer therapy
Zhao, Q., Chen, J., Zhang, Z., Xiao, C., Zeng, H., Chen, X., Yang, X., & Li, Z. (2023) · Biomaterials Science · doi:10.1039/d3bm00363a · Cited by 23
Zhao, L., Wen, S., Zhu, M., Li, D., Xing, Y. T., Shen, M., Shi, X., & Zhao, J. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1430696 · Cited by 22
“SLN mapping is an important tool to evaluate the nodal status for clinical cancer patient treatment [42].”
BackgroundPDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer
Hu, L., Zhang, P., Sun, W., Zhou, L., Chu, Q., & Chen, Y. (2020) · Medicine · doi:10.1097/md.0000000000019957 · Cited by 22
Lin, J., Lv, J., Yu, S., Chen, Y., Wang, H., & Chen, J. (2022) · Advanced Science · doi:10.1002/advs.202202633 · Cited by 21
Regulatory B cells producing IL‐10 are increased in human tumor draining lymph nodes
Piersiala, K., Hjalmarsson, E., da Silva, P. F. N., Lagebro, V., Kolev, A., Starkhammar, M., Elliot, A., Marklund, L., Munck‐Wikland, E., Margolin, G., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34555 · Cited by 23
“…is now hypothesized that the ICIs efficacy relies predominantly on the influx of newly primed T cells from TDLNs into tumor microenvironment, rather than on reinvigorating exhausted and fully differentiated T cells infiltrating tumors (TILs), 37 TDLNs have recently attracted increasing attention.”
BackgroundForces at play: exploring factors affecting the cancer metastasis
Riaz, F., Zhang, J., & Pan, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1274474 · Cited by 25
“It was revealed that LECs impact tumor progression and metastasis by signi fi cantly regulating the tumor cell-derived immune response within the TME (46, 47).”
BackgroundThe progressive trend of modeling and drug screening systems of breast cancer bone metastasis
Azar, H. K., Gharibshahian, M., Rostami, M., Mansouri, V., Sabouri, L., Beheshtizadeh, N., & Rezaei, N. (2024) · Journal of Biological Engineering · doi:10.1186/s13036-024-00408-5 · Cited by 23
“Some of the most important of these include stimulation of oncogenic signaling pathways, upregulation of TGF-β, tightening the ECM by activating fibroblast contraction, and angiogenesis in the opposite direction of interstitial flow [182].”
BackgroundModeling Tissue Polarity in Context
Tharp, K. M., & Weaver, V. M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.015 · Cited by 20
Mechanical stress-induced autophagic response: A cancer-enabling characteristic?
Das, J., Chakraborty, S. K., & Maiti, T. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.017 · Cited by 20
Mohammadalipour, A., Diaz, M. F., Livingston, M. K., Ewere, A., Zhou, A. L., Horton, P. D., Olamigoke, L. T., Lamar, J. M., Hagan, J. P., Lee, H. J., et al. (2022) · FASEB BioAdvances · doi:10.1096/fba.2021-00055 · Cited by 24
Xu, L., Li, J., Tursun, M., Hai, Y., Tursun, H., Mamtimin, B., & Hasim, A. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5373 · Cited by 20
“(1) Aminoacyl‐tRNA biosynthesis; (2) Valine, leucine and isoleucine biosynthesis; (3) glycolysis/gluconeogen‐ esis; (4) Glyoxylate and dicarboxylate metabolism; (5) glycine, serine and threonine metabolism; (6) arginine and proline metabolism; (7) valine, leucine and isoleucine degradation; (8) butanoate metabolism; (…”
BackgroundRoberts, L. M., Perez, M. J., Balogh, K. N., Mingledorff, G. A., Cross, J. V., & Munson, J. M. (2022) · Cancers · doi:10.3390/cancers14123008 · Cited by 23
“Moreover, coordination with the lymphatic system through fluid flow and drainage has been established as important in immunity and promoting immunosuppressive microenvironments [18,19,26,34,55].”
BackgroundRahman, Z., Bordoloi, A., Rouhana, H., Tavasso, M., van der Zon, G., Garbin, V., ten Dijke, P., & Boukany, P. E. (2023) · Lab on a Chip · doi:10.1039/d3lc00886j · Cited by 23
Metadata
- Authors
- Swartz, M. A., & Lund, A. W.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Swartz, Melody A.
- Venue
- Nature Reviews Cancer
- Published
- 2012-02-24
- Volume
- 12
- Issue
- 3
- Pages
- 210-219
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1985830305
- Semantic Scholar
- dde3a2ceebef487db2c0e2c5a80a8718f401a39b
- Cited by
- 544
- References
- 131
- Citations by year
- 2026: 32 · 2025: 32 · 2024: 35 · 2023: 41 · 2022: 37 · 2021: 46 · 2020: 52 · 2019: 33 · 2018: 51 · 2017: 50 · 2016: 32 · 2015: 29 · 2014: 27 · 2013: 37 · 2012: 9
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- tumor microenvironment, lymph flow, interstitial fluid flow, mechanobiology, mechanotransduction, tumor stroma, tumor immune evasion, tumor-draining lymph nodes, sentinel lymph node, tumour metastasis, tumor invasion, peripheral tolerance, tumor antigens
- MeSH terms
- Animals, Humans, Lymph Nodes, Lymphatic Metastasis, Neoplasms, Tumor Escape, Mechanotransduction, Cellular, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.